Please login to the form below

Not currently logged in
Email:
Password:

Questcor Pharmaceuticals

This page shows the latest Questcor Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'

Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'

Over the decades, other drugs superseded Acthar in many, but not all, indications, culminating in Aventis Pharmaceuticals selling the asset to Questcor for $100, 000 in 2001. ... Questcor allegedly increased the price to $750 immediately after buying the

Latest news

  • Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase

    This includes the $5.6bn deal for Questcor Pharmaceuticals last year and its purchase of Cadence Pharmaceuticals for $1.3bn.

  • Questcor MS drug wins new indication

    Questcor Pharmaceuticals has won US Food and Drug Administration approval of a new indication for its for HP Acthar Gel. ... Questcor Pharmaceuticals, which specialises in drugs for difficult-to-treat diseases, has won US Food and Drug Administration (FDA

  • The Pump House

    Hepatitis. China. Mecasermin rinfabate. Iplex (Insmed). Growth disorders. US. Methylphenidate. Methylin Chewable Tablets (Alliant Pharmaceuticals). ... Quazepam. (Questcor Pharmaceuticals). Insomnia. US. Risperidone. Generic risperidone (Actavis Group).

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Pharma deals during April 2014 Pharma deals during April 2014

    All told 24% of its revenues will come from in consumer health, 62% pharmaceuticals and 14% vaccines. ... wholesale takeovers with deals in Devices (Biomet/ Zimmer Holdings, AccessClosure/ Cardinal Health; New Wave Surgical/ Covidien), Generics/

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Questcor appoints SVP corporate strategic development Questcor appoints SVP corporate strategic development

    Michael Aldridge joins from Australian early development company Xenome. US biopharma Questcor Pharmaceuticals has named Michael Aldridge as its first senior VP, corporate strategic development. ... Development programmes that complement Acthar are also

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...